Internal Medicine, Hematology & Oncology · Fresno, CA
NPI
1144343005
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7130 N Millbrook Ave
Fresno, CA, 93720
Phone (559) 326-1222
Groups this clinician bills Medicare through
Medicare paid, 2024
$9.4M
532,837 services
Medicare patients, 2024
983
Average age 75
Drug cost, 2024
$4.9M
1,757 prescriptions
Company payments, 2025
$7,457
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sachin Gupta was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 136,800 times for 96 patients. In total Sachin Gupta billed 532,837 services in 208 codes, and Medicare paid $9.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 136,800 | 96 | $2.33 | $318K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 48,750 | 39 | $0.88 | $43K |
| J9299 Injection, nivolumab, 1 mg | Office | 29,640 | 27 | $24.59 | $729K |
| J0897 Injection, denosumab, 1 mg | Office | 23,880 | 106 | $20.49 | $489K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,000 | 25 | $44.58 | $847K |
| J0185 Injection, aprepitant, 1 mg | Office | 17,550 | 45 | $1.35 | $24K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 15,368 | 12 | $0.06 | $849 |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 15,300 | 11 | $0.02 | $297 |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 14,340 | 14 | $0.40 | $5,782 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 12,100 | 97 | $15.63 | $189K |
| J9173 Injection, durvalumab, 10 mg | Office | 11,298 | 19 | $63.71 | $720K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 11,000 | 32 | $4.39 | $48K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 9,840 | 21 | $35.62 | $350K |
| J1932 Injection, lanreotide, (cipla), 1 mg | Office | 7,080 | 13 | $35.87 | $254K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 7,000 | 16 | $37.08 | $260K |
By year: 2022 $9.0M for 714,732 services; 2023 $7.4M for 587,276 services; 2024 $9.4M for 532,837 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 2,643 | 85 | $19.89 | $53K |
| 85025 Blood Count | 2,592 | 557 | $7.61 | $20K |
| 36415 Venipuncture Blood Collection | 2,237 | 560 | $8.65 | $19K |
| 80053 Clinical Chemistry | 1,898 | 542 | $10.34 | $20K |
| 83540 Clinical Chemistry | 1,064 | 490 | $6.33 | $6,735 |
| 83550 Clinical Chemistry | 1,059 | 489 | $8.56 | $9,068 |
| 83615 Clinical Chemistry | 1,023 | 311 | $5.92 | $6,056 |
| 82728 Clinical Chemistry | 979 | 483 | $13.35 | $13K |
| 83735 Clinical Chemistry | 661 | 166 | $6.57 | $4,343 |
| 82607 Clinical Chemistry | 636 | 431 | $14.76 | $9,388 |
Medicare prescription drug claims, 2024
In 2024, the drug Sachin Gupta prescribed most often to Medicare patients was Pantoprazole Sodium, with 227 prescriptions and refills. In total Sachin Gupta wrote 1,757 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 227 | 289 | 62 | $1,391 |
| Metoclopramide Hcl Generic | 114 | 114 | 46 | $318 |
| Imbruvica Ibrutinib | 90 | 90 | 11 | $1.2M |
| Levothyroxine Sodium Generic | 65 | 156 | 23 | $760 |
| Ondansetron Hcl Generic | 60 | 60 | 39 | $2,497 |
| Warfarin Sodium Generic | 58 | 111 | Under 11 | $303 |
| Valacyclovir Valacyclovir Hcl | 55 | 80 | 17 | $2,640 |
| Eliquis Apixaban | 51 | 59 | 12 | $35K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 48 | 63 | 17 | $128 |
| Prednisone Generic | 47 | 56 | 20 | $243 |
| Levofloxacin Generic | 40 | 40 | 21 | $233 |
| Ondansetron Odt Ondansetron | 37 | 37 | 19 | $515 |
| Anastrozole Generic | 35 | 61 | Under 11 | $632 |
| Potassium Chloride Generic | 30 | 40 | Under 11 | $417 |
| Acyclovir Generic | 29 | 45 | Under 11 | $339 |
Brand drugs: 426 claims; generic drugs: 1,331 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sachin Gupta $7,457 ($7,457 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,891.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $3,891 |
| Astellas Pharma US Inc 4503.T | 2 | $2,029 |
| Abbvie Inc. ABBV | 4 | $779 |
| Heron Therapeutics, Inc. HRTX | 1 | $144 |
| Sandoz Inc. SDZ.SW | 2 | $123 |
| Pharmacosmos Therapeutics Inc. | 1 | $110 |
| Cardinal Health 108 LLC | 1 | $94.24 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $53.08 |
| Celgene Corporation BMY | 2 | $39.08 |
| Telix Pharmaceuticals TLX | 2 | $39.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.